🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sunjong Ji

University of Michigan

ORCID: 0000-0002-6516-2380

Also affiliated with Hunter Medical Research Institute, Michigan Medicine, Institute of Aging, University of Newcastle Australia

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma”.

Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma

Neuro-Oncology(2022)10.1093/neuonc/noac030
N/A
3.4DataRank · unranked
122 citations

Kyle Wierzbicki, Rohinton S. Tarapore, Karthik Ravi, Chase Thomas, Rodrigo T. Cartaxo +27 more

A road map for the treatment of pediatric diffuse midline glioma

Cancer Cell(2023)10.1016/j.ccell.2023.11.002
N/A
0.653DataRank · unranked
24 citations

Wajd N. Al‐Holou, Marta M. Alonso, Jamie N. Anastas, Pratiti Bandopadhayay, Tara Barron +70 more

A functional genomics screen identifying blood cell development genes inDrosophilaby undergraduates participating in a course-based research experience

G3 Genes Genomes Genetics(2021)10.1093/g3journal/jkaa028
N/A
0.563DataRank · unranked
14 citations

John M. Olson, Bama Charan Mondal, Pratyush Kandimalla, Ariano Abbasi, Mai Abdusamad +95 more

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0131
N/A
0DataRank · unranked
154 citations

Abed Rahman Kawakibi, Sunjong Ji, Sebastian M. Waszak, Stefan R. Sweha, Mateus Mota +79 more

Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations

Acta Neuropathologica(2023)10.1007/s00401-023-02640-7
N/A
0DataRank · unranked
35 citations

Sunjong Ji, Alberto Pïcca, Marc Sanson, Mekka Garcia, Matija Snuderl +25 more

Proximogram—A multi-omics network-based framework to capture tissue heterogeneity integrating single-cell omics and spatial profiling

Computers in Biology and Medicine(2024)10.1016/j.compbiomed.2024.109082
N/A
0DataRank · unranked
6 citations

Sunjong Ji, Ahmed M. Elhossiny, Achyutha Rao, Timothy L. Frankel, Arvind Rao +1 more

Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosis

Cancer Cell(2025)10.1016/j.ccell.2025.04.013
N/A
0DataRank · unranked
26 citations

Akash Deogharkar, John McKolay, Kyle Smith, Pooja Panwalkar, Simon Hoffman +40 more

Precision Oncology for High-Grade Gliomas: A Tumor Organoid Model for Adjuvant Treatment Selection

Bioengineering(2025)10.3390/bioengineering12101121
N/A
0DataRank · unranked
3 citations

Sunjong Ji, Habib Serhan, Reka Chakravarthy Raghunathan, Safiulla Basha Syed, Visweswaran Ravijumar +13 more

Assessing patient perception of risk in ocular stem cell therapies

Stem Cell Reports(2021)10.1016/j.stemcr.2021.09.001
N/A
0DataRank · unranked
2 citations

Sunjong Ji, Paula Anne Newman-Casey, Chris Andrews, Angeline Lonardi, Olivia M. Bennett +7 more

Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine

Frontiers in Oncology(2022)10.3389/fonc.2022.922928
N/A
0DataRank · unranked
44 citations

Dana Messinger, Jessica Cummings, Joshua Bradin, Abed Rahman Kawakibi, Clarissa May Babila +8 more